Overexpression of hypoxia-inducible factor-1 exacerbates endothelial barrier dysfunction induced by hypoxia

Cellular Physiology and Biochemistry

Volumn 32, Issue 4, 2013, Pages 859-870

  Wang, Pei ^a   Qi, Huabing ^a   Sun, Chunhong ^a   He, Wen ^a   Chen, Gang ^a   Li, Li ^a   Wang, Fengjun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Barrier dysfunction; Endothelial cell; Hypoxia; Hypoxia inducible factor 1; Myosin light chain kinase; Occludin; ZO 1

Indexed keywords

GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYOSIN LIGHT CHAIN KINASE; OCCLUDIN; PLASMID DNA; PROTEIN ZO1; TUMOR NECROSIS FACTOR ALPHA; CLAUDIN 1; GAMMA INTERFERON;

ARTICLE; ELECTRIC RESISTANCE; ENDOTHELIAL BARRIER DYSFUNCTION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; EXPRESSION VECTOR; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; PERMEABILITY BARRIER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSENDOTHELIAL ELECTRICAL RESISTANCE; WESTERN BLOTTING; CAPILLARY ENDOTHELIAL CELL; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; IN VITRO STUDY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

AMINO ACIDS, DICARBOXYLIC; BLOTTING, WESTERN; CELL HYPOXIA; CELL LINE; ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MYOSIN-LIGHT-CHAIN KINASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84888185167     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000354488     Document Type: Article

References (52)

1. Mehta D, Malik AB: Signaling mechanisms regulating endothelial permeability. Physiol Rev 2006;86:279-367
2. Bazzoni G, Dejana E: Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 2004;84:869-901 (Pubitemid 38823769)
3. Goddard LM, Iruela-Arispe ML: Cellular and molecular regulation of vascular permeability. Thromb Haemost 2013;109:407-415
4. Fishel RS, Are C, Barbul A: Vessel injury and capillary leak. Crit Care Med 2003;31:S502-S511
5. Ali MH, Schlidt SA, Hynes KL, Marcus BC, Gewertz BL: Prolonged hypoxia alters endothelial barrier function. Surgery 1998;124:491-497 (Pubitemid 28413345)
6. Sluimer JC, Daemen MJ: Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. J Pathol 2009;218:7-29
7. Schoch HJ, Fischer S, Marti HH: Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 2002;125:2549-2557 (Pubitemid 35303512)
8. Vogel C, Bauer A, Wiesnet M, Preissner KT, Schaper W, Marti HH, Fischer S: Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K/Akt pathway. J Cell Physiol 2007;212:236-243 (Pubitemid 46867606)
9. Kuhlmann CR, Tamaki R, Gamerdinger M, Lessmann V, Behl C, Kempski OS, Luhmann HJ: Inhibition of the myosin light chain kinase prevents hypoxia-induced blood-brain barrier disruption. J Neurochem 2007;102:501-507 (Pubitemid 47000593)
10. Semenza GL: Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Ann Rev Cell Dev Biol 1999;15:551-578 (Pubitemid 32250386)
11. Semenza GL: HIF-1 and human disease: one highly involved factor. Genes Dev 2000;14:1983-1991 (Pubitemid 30637348)
12. Semenza GL: HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 2001;13:167-171 (Pubitemid 32209217)
13. Semenza GL: Life with oxygen. Science 2007;318:62-64 (Pubitemid 47538005)
14. Semenza GL: Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology 2009;24:97-106
15. Qi H, Wang P, Liu C, Li M, Huang Y, Wang S, Wang F: Involvement of HIF-1? in MLCK-dependent endothelial barrier dysfunction in hypoxia. Cell Physiol Biochem 2011;27:251-262
16. Burick RK: Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci USA 2000;97:9082-9087
17. Cao M, Wang P, Sun C, He W, Wang F: Amelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway. PLoS One 2013;8:e61944
18. Koto T, Takubo K, Ishida S, Shinoda H, Inoue M, Tsubota K, Okada Y, Ikeda E: Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Am J Pathol 2007;170:1389-1397 (Pubitemid 47339345)
19. Zhu H, Wang Z, Xing Y, Gao Y, Ma T, Lou L, Lou J, Gao Y, Wang S, Wang Y: Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells. J Ethnopharmacol 2012;141:714-720
20. Mark KS, Davis TP: Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol 2002;282:H1485-H1494 (Pubitemid 34654903)
21. Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, Turner JR: Interferon-? and tumor necrosis factor-? synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 2005;166:409-419 (Pubitemid 40189038)
22. Ma TY, Boivin MA, Ye D, Pedram A,Said HM: Mechanism of TNF-α modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol 2005;288:G422-G430 (Pubitemid 40261739)
23. Wang F, Schwarz BT, Graham WV, Wang Y, Su L, Clayburgh DR, Abraham C, Turner JR: IFN-γ-Induced TNFR2 up-regulation is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology 2006;131:1153-1163 (Pubitemid 44515106)
24. Schwarz BT, Wang F, Shen L, Clayburgh DR, Su L, Wang Y, Fu YX, Turner JR: LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms. Gastroenterology 2007;132:2383-2394 (Pubitemid 46900820)
25. Liu H, Li M, Wang P, Wang F: Blockade of hypoxia-inducible factor-1 by YC-1 attenuates interferon-? and tumor necrosis factor-?-induced intestinal epithelial barrier dysfunction. Cytokine 2011;56:581-588
26. Liu H, Wang P, Cao M, Li M, Wang F: Protective role of oligomycin against intestinal epithelial barrier dysfunction caused by IFN-γ and TNF-α. Cell Physiol Biochem 2012;29:799-808
27. Chen C, Wang P, Su Q, Wang S, Wang F: Myosin light chain kinase mediates intestinal barrier disruption following burn injury. PLoS One 2012;7:e34946
28. Al-Sadi R, Ye D, Dokladny K, Ma TY: Mechanism of IL-1?-induced increase in intestinal epithelial tight junction permeability. J Immunol 2008;180:5653-5661
29. Al-Sadi R, Guo S, Dokladny K, Smith MA, Ye D, Kaza A, Watterson M, Ma TY: Mechanism of interleukin-1? induced-increase in mouse intestinal permeability in vivo. J Interf Cytok Res 2012;32:474-484
30. Witt KA, Mark KS, Huber J, Davis TP: Hypoxia-inducible factor and nuclear factor kappa-B activation in blood-brain barrier endothelium under hypoxic/reoxygenation stress. J Neurochem 2007;102:501-507
31. Aslam M, Schluter KD, Rohrbach S, Rafiq A, Nazli S, Piper HM, Noll T, Schulz R, Gunduz D: Hypoxia-reoxygenation-induced endothelial barrier failure: role of RhoA, Rac1 and myosin light chain kinase. J Physiol 2013;591:461-473
32. Singh N, Sharma G, Mishra V, Raghubir R: Hypoxia inducible factor-1: its potential role in cerebral ischemia. Cell Mol Neurobiol 2012;32:491-507
33. Morote-Garcia JC, Rosenberger P, Kuhlicke J, Eltzschig HK: HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood 2008;111:5571-5580
34. Furuta GT, Turner JR, Taylor CT, Hershberg RM, Comerford K, Narravula S, Podolsky DK, Colgan SP: Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J Exp Med 2001;193:1027-1034 (Pubitemid 32436196)
35. Karhausen J, Furuta GT, Tomaszewski JE, Johnson RS, Colgan SP, Haase VH: Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest 2004;114:1098-1106 (Pubitemid 39578699)
36. Robinson A, Keely S, Karhausen J, Gerich ME, Furuta GT, Colgan SP: Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology 2008;134:145-155 (Pubitemid 350309309)
37. Olson N, Hristova M, Heintz NH, Lounsbury KM, van der Vliet A: Activation of hypoxia-inducible factor-1 protects airway epithelium against oxidant-induced barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2011;301:L993-L1002
38. Yeh WL, Lu DY, Lin CJ, Liou HC, Fu WM: Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1? accumulation and VEGF expression. Mol Pharmacol 2007;72:440-449
39. Higashida T, Kreipke CW, Rafols JA, Peng C, Schafer S, Schafer P, Ding JY, Dornbos D, Li X, Guthikonda M, Rossi NF, Ding Y: The role of hypoxia-inducible factor-1alpha, aquaporin-4, and matrix metalloproteinase-9 in blood-brain barrier disruption and brain edema after traumatic brain injury. J Neurosurg 2011;114:92-101
40. Yan J, Zhou B, Taheri S, Shi H: Differential effects of HIF-1 inhibition by YC-1 on the overall outcome and blood-brain barrier damage in a rat model of ischemic stroke. PLoS One 2011;6:e27798
41. Wang Z, Meng CJ, Shen XM, Shu Z, Ma C, Zhu GQ, Liu HX, He WC, Sun XB, Huo L, Zhang J, Chen G: Potential contribution of hypoxia-inducible factor-1alpha, aquaporin-4, and matrix metalloproteinase-9 to blood-brain barrier disruption and brain edema after experimental subarachnoid hemorrhage. J Mol Neurosci 2012;48:273-280
42. Yan J, Zhang Z, Shi H: HIF-1 is involved in high glucose-induced paracellular permeability of brain endothelial cells. Cell Mol Life Sci 2012;69:115-128
43. Chen W, Jadhav V, Tang J, Zhang JH: HIF-1? inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model. Neurobiol Dis 2008;31:433-441
44. Yamagata K, Tagami M, Takenaga F, Yamori Y, Itoh S: Hypoxia-induced changes in tight junction permeability of brain capillary endothelial cells are associated with IL-1beta and nitric oxide. Neurobiol Dis 2004;17:491-499 (Pubitemid 39574881)
45. Fischer S, Wiesnet M, Marti HH, Renz D, Schaper W: Simultaneous activation of several second messengers in hypoxia-induced hyperpermeability of brain derived endothelial cells. J Cell Physiol 2004;198:359-369 (Pubitemid 38235031)
46. Kannan KB, Colorado I, Reino D, Palange D, Lu Q, Qin X, Abungu B, Watkins A, Caputo FJ, Xu DZ, Semenza GL, Deitch EA, Feinman R: Hypoxia-inducible factor plays a gut-injurious role in intestinal ischemia reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2011;300:G853-618
47. Shah YM, Ito S, Morimura K, Chen C, Yim SH, Haase VH, Gonzalez FJ: Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. Gastroenterology 2008;134:2036-2048
48. Rosenberger P, Khoury J, Kong T, Weissmuller T, Robinson AM, Colgan SP: Identification of vasodilator-stimulated phosphoprotein (VASP) as an HIF-regulated tissue permeability factor during hypoxia. FASEB J 2007;20:2613-2621 (Pubitemid 47230689)
49. Kuhlmann CR, Tamaki R, Gamerdinger M, Lessmann V, Behl C, Kempski OS, Luhmann HJ: Inhibition of the myosin light chain kinase prevents hypoxia-induced blood-brain barrier disruption. J Neurochem 2007;102:501-507 (Pubitemid 47000593)
50. Zahs A, Bird MD, Ramirez L, Choudhry MA, Kovacs EJ: Anti-IL-6 antibody treatment but not IL-6 knockout improves intestinal barrier function and reduces inflammation following binge ethanol exposure and burn injury. Shock 2013;39:373-379
51. Jeong HJ, Hong SH, Park RK, Shin T, An NH, Kim HM: Hypoxia-induced IL-6 production is associated with activation of MAP kinase, HIF-1, and NF-kappaB on HEI-OC1 cells. Hear Res 2005;207:59-67 (Pubitemid 41317235)
52. Feinman R, Deitch EA, Watkins AC, Abungu B, Colorado I, Kannan KB, Sheth SU, Caputo FJ, Lu Q, Ramanathan M, Attan S, Badami CD, Doucet D, Barlos D, Bosch-Marce M, Semenza GL, Xu DZ: HIF-1 mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2010;299:G833-G843.